New Blood Test May Detect Preclinical Alzheimers Years in Advance

A new blood test that identifies a variant of the protein P53 appears to predict Alzheimer’s disease (AD) progression up to 6 years in advance of a clinical diagnosis, early research suggests. Analysis of two studies showed the test (AlzoSure Predict), which uses less than 1 ml of blood, had numerous benefits compared with other blood tests that track AD […]
Continue reading »